<DOC>
	<DOC>NCT01938105</DOC>
	<brief_summary>The purpose of this study is to determine the feasibility and efficacy of preoperative nimotuzumab injection combined with concurrent chemoradiotherapy for initially inoperable, locally advanced cervical cancer.</brief_summary>
	<brief_title>Preoperative Chemoradiotherapy Combined With Nimotuzumab for Cervical Cancer</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Histologically or cytologically proven squamous cell cervical cancer Stages IB2IIIB according to FIGO Staging System Age:1875 ECOGï¼œ2 Normal bone marrow function Initial assessed and considered not candidates for operation Signed studyspecific consent form Pregnant or lactating women Patients with other malignancies Patients who received radiotherapy or chemotherapy previously Presence of uncontrolled lifethreatening illness Allergy to platinum or monoclonal antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Cervical cancer</keyword>
	<keyword>Nimotuzumab</keyword>
	<keyword>Intensity-modulated radiation therapy</keyword>
	<keyword>Concurrent chemoradiotherapy</keyword>
</DOC>